Key risks
- High valuation (PE 74.99) embeds significant growth expectations; any earnings disappointment or margin pressure could trigger sharp stock correction.
- Elevated leverage (D/E 1.76) limits financial flexibility; rising interest rates or slowing revenue growth could compress net profit despite current ROE of 27%.
- Operating margin volatility of 6.5 percentage points (32.31%–38.81% across recent quarters) signals exposure to input costs, forex fluctuations, or product-mix shifts—verify sustainability.
- Pharmaceutical pricing pressure from regulators erodes margins on high-volume generics; verify Torrent's exposure to price-controlled segments and product mix.
Generated analysis · source review pending